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Clear cell papillary renal cell carcinoma, renal angiomyoadenomatous 
tumor and renal cell carcinoma with leiomyomatous stroma-
relationship of three types of renal tumors. A review. 
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Abstract 
Renal angiomyoadenomatous tumor has been described in 2000, 
followed by description of clear cell papillary renal cell carcinoma in 
2006. Discussion about possible relationship of both tumors were 
published since their description. As the main differencial diagnostic 
feature was considered presence/absence of fibroleiomyomatous 
stroma favoring diagnosis of RAT in stroma-rich tumors. However it 
was shown, that stroma is reactive, non-neoplastic by its nature and 
that all other histologic, immunohistochemical, and molecular-genetic 
features of both entities are identical. In upcomming WHO 
classification of renal tumors (2016) both lesions are considered as 
single entity (CCPRCC). Vaste majority of the published cases 
followed benign/indolent clinical course. Also vaste majority of the 
tumors has normal status of VHL gene (methylation, LOH 3p, 
mutations), however CCPRCC was referred in patients with VHL 
syndrome, Another issue covered by this review is possible 
relationship of CPRCC and „renal cell carcinoma with 
leiomyomatous stroma“ (RCCLS). RCCLS shows clear cell cytology, 
abundand leiomyomatous stroma. Some of RCCLS are positive for 
CK 7, some negative. Similar situation exists for relation of RCCLS 
and VHL gene abnormalities. It is so far unclear, whether any relation 
between CCPRCC and RCCLS exists. From all published studies 
seems that these tumors are less likely each other related. 
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Introduction 
Renal angiomyoadenomatous tumor (RAT) has been described by 
Michal et al in 2000 in form of case report, and later in 2009 as series 
of 5 cases. Since initial description, several reports describing this 
distinct renal tumor have been published (1-4) (Fig 1). 
Morphologically, RATs are composed of tubules, small compact nests 
and abortive papillae lined by neoplastic columnar epithelial cells with 
optically clear cytoplasm, frequently with an apical „blister“ quality 
and low-grade (Fig 2), basally located  nuclei, a well-developed 
peritubular capillary network and slightly open, variably angulated 
tubules which have been likened to the „shark smile“ (Fig 3) and 
variable presence of a leiomyomatous/myofibroblastic stroma (Fig 4). 
Immunohistochemically, the neoplastic epithelial cells of RAT 
express carbonic anhydrase-9 (CANH 9) (cup-shape pattern), CK7, 
PAX8 while expression of vimentin, CD10 and racemase (AMACR)
is variable. 
Clear cell papillary renal cell carcinoma (CCPRCC) has been 
introduced in 2006 by Tickoo et al in end-stage kidney disease. 
Majority of the cases reported since initial description have been 
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recognized in non-atrophic kidney (5-8). Numerous studies were 
addressed to further characterization of this relatively common, 
previously under-recognized renal tumor. 
According ISUP Vancouver Classification 2012 CCPRCC is well 
circumscribed and well encapsulated. The cut surface is whitish to tan. 
Tumors are composed of clear cells of low nuclear grade, variable 
papillary, tubular/acinar, and cystic architecture, and a characteristic 
linear arrangement of nuclei away from the basal aspect of cells (Fig 
5). Immunohistochemical profile is nearly identical with RAT, ie 
tumors are positive for CK7 (Fig 6), CANH 9, high-molecular weight 
cytokeratin positivity and CD10 and AMACR negativity (9).
Coexpression of CK 7, which is by definition diffuse and strong, and 
CANH 9 is usually consider as immunohistochemical landmark of 
CCPRCC. Expression of CANH 9 is mostly diffuse with characteristic 
cup-like shape pattern (7). Such pattern correspond with shape of 
neoplastic cells. Typically they are cylindrical with elongated blister-
shape snouts in luminal aspect of neoplastic glands. Apical portion of 
such cells is negative for CANH 9, thus “cup-shape” of the 
membranous positivity is obvious.  
Relationship of clear cell papillary RCC and RAT
RAT and CCRCC share almost equal morphology and 
immunophenotype. Both types are characterized by the presence of 
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fibroleiomyomatous stroma and CK 7 positivity, they also bear similar 
molecular genetic attributes (lack of VHL gene abnormalities) (10,
11). Presumably, the difference between them inheres in stromal 
component, in the sense that RAT exhibit a voluminous stromal 
component and CCPRCC, in contrast, usually features a much less 
prominent smooth muscle stroma. 
There is no strict line between CCPRCC and RAT. Minimum 
volume/amount of stroma has never been defined. Thus it is very 
subjective issue without exact criteria for differential diagnostic 
process. 
However, the presence of the abundant fibroleiomyomatous stroma 
has been becoming as an important mark of distinction between RAT 
and CCPRCC and hence these two entities are regarded as related 
tumors and viewed as two ends of spectrum of one nosologic entity in 
ISUP 2012 (9). 
Two multicentric studies have been published recently (7, 8). As 
conclusion of both papers is obvious, that RAT and CCPRCC are 2 
morphologic ends of one etiologic entity. Similar view will be 
expressed in upcoming WHO classification 2016.  
CCPRCC/RAT differential diagnosis
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Majority of the cases are easily recognizable tumors with 
characteristic morphology. There are several issues which should be 
addressed: 
Clear cell renal cell carcinoma with RAT-like areas. 
Morphologic changes resembling CCPRCC can be seen within 
“typical” CCRCC. Such changes can produce tubopapillary 
architecture, “shark smiles”, even blister like proliferation within 
lumens of cystic or tubular changes. In typical CCRCC such areas are 
mostly CK 7 negative.
However, CCRCC are considered as CK 7 negative tumor, but it is 
possible to find cases with strong CK 7 positivity. Expression of CK 7 
in CRCC (albeit not strong and diffuse) has been documented by 
Gatalica et al as early as 1995. (12) The authors described 
immunoreactivity for CK7 in 24% of classic CRCC.  Thus according 
our opinion, CK 7 immunoreactivity is one of the key diagnostic 
feature for CCPRCC, but should be interpreted with caution. 
Mimickers of CCPRCC/RAT has been described in literature (13) 
(14). In all cases in series of Petersson et all resembled CCPRCC/RAT 
by morphology and also by some aspects of immunohistochemical 
profile (Fig 7). Majority of the cases demonstrated some degree of 
abnormalities on morphologic, immunohistochemical or molecular 
genetic level. Coexpression of strong immunoreactivity for CK7 and 
AMACR in tumors with overlapping features of both CCRCC and 
both CCPRCC have been documented, altogether with abnormalities 
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of VHL gene and numerical chromosomal aberrations (15). It was also 
clearly shown that „aberrant“ expression of cytokeratin 7 and 
AMACR in CRCC should not lead the diagnostician astray from a  
diagnosis of  CRCC. (15)
Another group of tumors which should be taken into the consideration 
in differential diagnosis is MiT family (translocation) renal cell 
carcinomas group, mostly tumors associated with Xp11.2 
translocation. These tumors are morphologically variable, mostly are 
arranged in papillary pattern and are composed of large, weakly 
eosinophilic or clear cells. There is no general morphologic feature 
specific for Xp11.2 RCCs. However tumors usually display 
tubulopapillary or papillary pattern, are composed of clear cell 
elements with psammoma bodies, eosinophilic hyaline nodules and 
occur mostly in younger patients. All tumors express TFE3 protein, 
albeit immunohistochemical detection is very problematic and a 
number of false positive/negative cases can be expected (16) (9). Thus 
more reliable is a TFE3 break-apart FISH assay, which works on 
paraffin-embedded tissue (9, 17) (18). Cathepsin K was referred as 
reliable diagnostic tool for translocation RCC (19). Translocation 
RCC is further negative or only weakly and focally positive for 
keratins (including CK 7) and EMA, negative for racemase  
(AMACR) and CANH-9. Translocation RCC is positive with the 
antibody to vimentin and strongly positive with CD10. RAT/CCPRCC 
is low-grade tumor without psammoma bodies and hyaline nodules. 
For RAT/CCPRCC characteristic “shark-smiles” are not present in 
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translocation RCC, a swell as smooth muscle stroma. RAT/CCPRCC 
is diffusely positive for CK 7 and CANH-9, negative for TFE3 and 
cathepsin K. 
VHL gene and CCPRCC/RAT
Mostly it is accepted, that CCPRCC/RAT has no changes in VHL gene
(methylation, mutation) and has not LOH3p.  However, recently 
CCPRCC has been referred in patient with VHL syndrome(20).
Another studies describing CCPRCC showed abnormalities in VHL 
gene in 3 out of 37 cases of RAT/CCPRCC (8), and in about one third 
of the patients(21). 
Based on detailed search in literature, analysis of our own cases seems 
that cases with doubtful morphology and/or unusual 
immunohistochemical profile bearing any VHL gene abnormalities 
should be not be classified as CCPRCC/RAT. In tumors, where the 
morphology is typical and immunohistochemical features are 
compatibile with the diagnostic of CCPRCC/RAT caution is needed, 
when any VHL gene (including LOH 3p and hypermethylation)
abnormality is found.  The reason is obvious. CCPRCC is a renal 
tumor with minimal aggressive potential. We are aware of case report 
presented in ECP in 2015, where the authors showed aggressive 
metastazing. RAT/CCPRCC (22). Detailed study dealing with 
prognosis of  RAT/CCPRCC has been published recently. Authors 
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made exhaustive search in the English-written literature and found 
268 reported cases and carefully examined their own series of 32 
cases. Metastatic activity was approved only in 2 patients, in 1 patient 
suspect metastatic structures were found using imaging methods. The
vast majority of RAT/CCPRCC documented in literature followed 
benign course (23). As we have minimal evidence of biologic 
behavior of RAT/CCPRCC mimickers, caution is needed when 
pathologists face such tumor. Both low-grade CCRCC, and PRCC can 
behave aggressively and patient should be carefully followed.  
Renal cell carcinomas with a prominent smooth muscle stroma
Renal cell carcinomas with a prominent smooth muscle stroma 
(RCCSMS) are rare neoplasms. First case has been described by 
Canzonieri et al. in 1993 and subsequently documented by Kuhn et al 
in 2006 and others (24-27). Histologically RCCSMSs are composed of 
an intimate intermixture of two distinct components: epithelial and 
stromal. The epithelial component is represented by clear epithelial 
cells with mild nuclear atypia (mostly nuvleolar ISUP/Fuhrman grade 
2) arranged in adenomatous structures with predominantly nested or 
tubular pattern associated with focal papillary and solid areas (Fig 8).
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Exact diagnostic criteria are not established. Morphology and 
immunohistochemical features (namely CK 7 positivity among others) 
are variable in previous studies. 
Tuberous sclerosis complex and RAT/CCPRCC
Guo et all described recently series of RCC occurring in patients with 
tuberous sclerosis complex (TS). 30% of RCC described in this study 
had features similar to tumors previously described as "renal
angiomyoadenomatous tumor" or "RCC with smooth muscle stroma"; 
59% showed features similar to chromophobe RCC; and 11% showed 
a granular eosinophilic-macrocystic morphology (so-called solid and 
cystic RCC) (28).
Besides above cited paper, RATs described in the literature were 
present in the background of end-stage-kidney or in sporadic settings. 
Also cases described under the term CCPRCC were not part of TS 
complex. 
CCPRCC/RAT and RCC with leiomyomatous stroma
It was pointed out by Martignoni et al, that RCCSMS is tumor distinct 
from clear cell RCC and that these tumors could be related to 
RAT/CCPRCC (29). Our results indicate, at least on the morphologic 
and immunohistochemical level, that there are some differences 
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between RCCSMS and RAT/CCPRCC. Further studies with a larger 
cohort of patients should be performed to confirm any possible link 
between RCCSMS and CCPRCC/RAT.  
Leiomyomatous stroma is mostly reactive, non-neoplastic tissue, 
possibly derived from vascular structures as it is indicated by 
immunohistochemical profile. Leiomyomatous stroma is not restricted 
to renal tumors like RAT or RCCSMS. It was shown in otherwise 
typical clear cell RCC or in papillary RCC (30). We believe that 
leiomyomatous/fibroleiomyomatous stroma is just reactive condition, 
which not preclude any particular diagnosis. Hence tumors with clear 
cell morphology and voluminous stromal component should be tested 
for VHL gene abnormalities. It is possible to speculate about 
relationship between CCPRCC/RAT and RCCSMS only in tumors, 
which are VHL gene mutation, hypermethylation (and LOH3p) 
negative and CK 7 positive (Fig 9).
We have analyzed 8 cases of RCCSMS with VHL gene abnormalities 
and without such changes using next generation sequencing. We were 
not able to find any VHL gene abnormality using NGS (Fig 10). Also 
compared our results with NGS study conducted by Lawrie et al. 
Authors analyzed 17 CCPRCC/RAT and they found that EMT in 
CCPRCC tumor cells is incomplete or blocked, consistent with the 
indolent clinical course typical of this malignancy (31). We were not 
able to disclose any similar genetic changes in both groups (cases with 
VHL gene abnormalities and cases without abnormalities) of 
RCCSMS (Ondrej Hes, unpublished data).
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TCEB-1 mutated RCC and RCCSMS
Peculiar renal tumors composed of clear cells and distinct 
leiomyomatous stroma have been docummented recently.
Pathologically, all TCEB1-mutated tumors shared characteristic 
features including thick fibromuscular bands transecting the tumor, 
pure clear cell cytology frequently with cells showing voluminous 
cytoplasm, and clear cell renal cell carcinoma-like acinar areas 
associated with infolding tubular and focally papillary architecture. 
Such tumors harbored TCEB-1 gene mutations, lacked LOH 3p. 
According authors, the presence of voluminous cytoplasm, absence of 
luminal polarization of tumor nuclei, and lack of extensive cup-like 
distribution of carbonic anhydrase-IX expression distinguish it from 
clear cell papillary carcinoma. (32) 
From the photodocumentation and description is obvious that TCEB-1
tumors are morphologically similar to RCCSMS. As the authors 
mentioned, morphology and immunohistochemical profile of TCEB1-
mutated tumors is different from RAT/CCPRCC. From morphological 
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point of view it would be extremely difficult to distinguish TCEB1-
mutated tumor from RCCSMS and seems that molecular genetic 
analysis of TCEB-1 gene would be in such tumors beneficial part of 
analytical algorythm.
As we have mentioned earlier, we have performed NGS analysis of 
RCCSMS. We have not be able to show any TCEB-1 abnormalities in 
both groups (Hes, unpublished results). 
As a summary it is possible to conclude, that RAT and CCPRCC are 
two morphologic ends of one nosologic entity. Vaste majority of the 
published cases followed benign/indolent clinical course. Tumors 
displaying similar morphologic attributes, ie mostly clear cell low-
grade population and abundand leiomyomatous stroma are designated 
as renal cell carcinomas with leiomyomatous stroma. It is so far 
unclear, whether any relation between CCPRCC and RCCLS exists. 
Disclosure of Conflict of Interest  
 All authors declare no conflict of interest. 
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Legends to figures 
Fig 1: Typical clear cell papillary renal cell carcinoma (RAT). Tumor 
is encapsulated by thick whitish tissue with prominent septae crossing 
neoplastic mass. 
Fig 2: Clear cell papillary renal cell carcinoma (RAT) is composed of 
tubules, small compact nests and abortive papillae lined by neoplastic 
columnar epithelial cells with optically clear cytoplasm, with an apical 
„blister“ quality and low-grade, basally located  nuclei. 
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Fig 3: Angulated tubules which have been likened to the „shark smile“ 
seen scattered in neoplastic mass 
Fig 4: Capsule and leiomyomatous stroma is clearly visible in 
histotopogram of clear cell papillary renal cell carcinoma (RAT). 
Fig 5: Linear arrangement of nuclei away from the basal aspect of 
cells is characteristic feature for clear cell papillary renal cell 
carcinoma (RAT). 
Fig 6: Clear cell papillary renal cell carcinoma (RAT) is diffusely 
positive for CK 7. 
Fig 7: Clear cell papillary renal cell carcinoma mimicker. This tumor 
was diagnosed as clear cell renal cell carcinoma (morphology 
supported by abnormalities in VHL gene and negative reaction with 
CK 7). A, Gross section demonstrated fibroleiomaomatous capsule 
and prominent leiomyomatous component. B, Tumor is composed of 
low-grade clear cells arranged in tubulopapillary pattern. Basally 
oriented nuclei are clearly visible. C, CK 7 is strongly, but focally 
positive. 
Fig 8: Renal cell carcinomas with a prominent smooth muscle stroma.
Histologically tumors are composed of an intimate intermixture of two 
distinct components: clear cell epithelial and leiomyomatous. This 
tumor was negative for all VHL gene abnormalities and positive for 
CK 7.
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Fig 9: Another example of tumor, of which morphology is compatible 
with diagnosis of renal cell carcinomas with a prominent smooth 
muscle stroma. However, this particular case was positive for CK 7 
and VHL gene mutation was detected.
Fig 10: Another case, which has morphologic features of renal cell 
carcinomas with a prominent smooth muscle stroma. Tumor was 
negative for CK 7 and we were not able to find any VHL gene
abnormalities.
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Figure 1 
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Figure 2 
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Figure 3 
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Figure 4 
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Figure 5 
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Figure 6 
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Figure 7A 
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Figure 7B 
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Figure 7C 
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Figure 8 
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Figure 9 
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Figure 10 
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“ Clear cell papillary renal cell carcinoma, renal 
angiomyoadenomatous tumor and renal cell carcinoma with 
leiomyomatous stroma-relationship of three types of renal tumors. A 
review.”-highlights
1, Paper describes author´s opinion about three different neoplastic 
entities occuring in the kidney. 
2, Relation of renal angiomyoadenomatous tumor and clear cell 
papillary renal cell carcinoma will be discussed in upcoming WHO 
2016 classification. Authors expressed their opinion in context of new 
WHO classification. 
3, Relation of VHL gene mutations and abnormalities and above 
mentioned renal tumors is discussed in detail. 
4, Morphologic and molecular genetic characteristics of renal cell 
carcinoma with leiomyomatous stroma are described as well as 
relation between renal angiomyoadenomatous tumor/ clear cell 
papillary renal cell carcinoma and renal cell carcinoma with 
leiomyomatous stroma.
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